For crores of Indian families, the financial shock of hospitalisation — especially in a private hospital — begins even before treatment is complete. The Parliamentary Standing Committee on Health and Family Welfare, in its 176th Report tabled in Parliament on August 7, 2026, noted that the average cost of hospitalisation is ₹50,508 in a private facility, compared with ₹6,631 in a government facility. For childbirth, the average out-of-pocket medical expenditure in private facilities is ₹37,630, against ₹2,299 in public facilities.
Among the widely reported proposals is that basic room tariffs in metropolitan private hospitals should not exceed the average tariff of three-star hotels that are nearby. It has also suggested that large corporate hospitals earning from medical tourism, foreign patients and high-net-worth individuals should cross-subsidise poorer Indians and reserve beds for Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) beneficiaries at regulated rates. Yet, there is a contradiction. There is a strong case for continued investment in Indian health care. Hospitals require substantial capital. Land, equipment, intensive care units, digital systems, laboratories and trained personnel are expensive. Public hospitals cannot currently meet all demand for secondary and tertiary care. Foreign investors and private-equity funds can bring capital, managerial capacity, technology and the capacity to expand hospital networks. India also needs investment in pharmaceutical and medical-device manufacturing. If regulation becomes excessively restrictive or unpredictable, some investment may move elsewhere. This could slow capacity expansion and delay the development of better health-care infrastructure in cities and districts where need is genuine. However, in all sectors, capital comes with expectations of returns. A patient rarely decides independently whether an MRI is required, whether hospital admission should continue for two more days, or whether a procedure is necessary. Health care is shaped by what economists call information asymmetry: the provider knows more than the patient. This is where the role of private equity and venture capital in health care deserves closer attention. Corporate hospital groups increasingly compete for well-known specialists, sophisticated technology and premium infrastructure. These can improve quality, but also create a high-cost ecosystem. Hospitals that pay very high salaries to senior specialists and super-specialists, acquire expensive equipment and operate under pressure to increase revenue must eventually recover these costs. Revenue targets, procedure-linked incentives, higher occupancy expectations and higher revenue per bed can gradually influence institutional behaviour. Most doctors act in patients’ interests. Yet, systems shape behaviour. If hospitals and doctors are rewarded for doing more, the direction becomes predictable. Price regulation also needs to be approached carefully. The proposal to link hospital room charges to nearby three-star hotels is easy to understand, but cannot by itself solve the affordability problem. A hospital room includes nursing, infection-control and emergency support that a hotel room does not. More importantly, if one component of the bill is capped, hospitals may increase charges elsewhere. India’s experience with coronary stent price regulation showed that government intervention can reduce excessive mark-ups. But hospital care is more complex; what matters is the total cost of an episode. There is also an established approach to such payments: Diagnosis-Related Groups (DRG). A DRG is a patient-classification system that standardised hospital reimbursement by paying a fixed, predetermined amount for an inpatient stay based on the diagnosis and procedures, rather than reimbursing each service separately. Insurance systems, including AB-PMJAY, should reward appropriate care rather than simply higher volumes of procedures. Clinical audits, evidence-based treatment protocols and transparent billing can protect both patients and doctors from commercial pressures.
Private hospitals therefore fill an important gap. Because patients are not ordinary consumers, in health care, it creates a special concern. Therefore, when financial incentives become too strong, they can influence not just the price of care but also how much care is delivered. Package rates, transparent estimates, billing standards and audit mechanisms are therefore more useful than isolated caps on individual components. Public hospitals must therefore become a genuine option, not merely the last resort for those who cannot afford private care. Primary health care needs strengthening so that disease is prevented, detected and treated early.
The committee has made 368 recommendations, including standardised package rates and mandatory pre-treatment cost estimates. India wants more private and foreign capital in health care, particularly in Tier-2, Tier-3 and rural areas, while simultaneously asking the government to review foreign direct investment rules related to the acquisition and management of existing hospitals.
